Detalhe da pesquisa
1.
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.
Immunity
; 46(1): 148-161, 2017 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986455
2.
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.
Cancer
; 130(10): 1758-1765, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422026
3.
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Hum Genomics
; 17(1): 66, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461096
4.
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.
Nature
; 557(7706): 575-579, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769722
5.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer
; 129(23): 3772-3782, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769113
6.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
7.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
8.
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(9): 813-824, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846060
9.
Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types.
Genome Res
; 30(6): 803-813, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661091
10.
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 13-21, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516023
11.
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures.
Cancer Immunol Immunother
; 71(4): 989-998, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580764
12.
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.
Immunity
; 48(5): 1060, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768165
13.
Revisiting neoadjuvant therapy in non-small-cell lung cancer.
Lancet Oncol
; 22(11): e501-e516, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735819
14.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Lancet Oncol
; 22(7): 959-969, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118197
15.
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
Br J Cancer
; 125(5): 687-698, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140638
16.
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 261-270, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838015
17.
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.
Oncologist
; 25(1): e160-e169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395751
18.
Circulating extracellular vesicle-associated TGFß3 modulates response to cytotoxic therapy in head and neck squamous cell carcinoma.
Carcinogenesis
; 40(12): 1452-1461, 2019 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436806
19.
Single-cell multimodal profiling reveals cellular epigenetic heterogeneity.
Nat Methods
; 13(10): 833-6, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525975
20.
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
Invest New Drugs
; 37(2): 271-281, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073466